Presentation is loading. Please wait.

Presentation is loading. Please wait.

Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality.

Published byDoreen Grant Modified over 5 years ago

Similar presentations

Presentation on theme: "Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality."— Presentation transcript:

1 Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality of life  Kimberly S. Corbin, MD, Rangesh Kunnavakkam, MS, Scott E. Eggener, MD, Stanley L. Liauw, MD  Practical Radiation Oncology  Volume 3, Issue 2, Pages (April 2013) DOI: /j.prro Copyright © 2013 American Society for Radiation Oncology Terms and Conditions

2 Figure 1 Global domain scores after postprostatectomy radiation therapy. The asterisk represents scores that were statistically different (P < .05, t test) to the baseline value. Standard error is shown by the vertical lines. Practical Radiation Oncology 2013 3, DOI: ( /j.prro ) Copyright © 2013 American Society for Radiation Oncology Terms and Conditions

Download ppt "Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality."

Similar presentations

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.
Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer  Thomas J. Pugh, MD, Mark F.

Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer  Thomas J. Pugh, MD, Mark F.
Colloquium on Therapy of Right Heart Failure

Colloquium on Therapy of Right Heart Failure
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.

Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.
Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center  Kristina D. Woodhouse, MD, Wei-Ting.

Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center  Kristina D. Woodhouse, MD, Wei-Ting.
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy  William.

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy  William.
Volume 4, Issue 5, Pages (September 2017)

Volume 4, Issue 5, Pages (September 2017)
Aaron S. Kusano, MD, SM, Matthew J

Aaron S. Kusano, MD, SM, Matthew J
Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3.

Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3.
Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.

Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.
Should we irradiate a brain tumor in a patient with parkinsonism

Should we irradiate a brain tumor in a patient with parkinsonism
Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.
Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K
Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S

Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S
Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary  Lawrence B. Marks, MD, Robert.

Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary  Lawrence B. Marks, MD, Robert.
Brenda G. Clark, PhD, Robert J

Brenda G. Clark, PhD, Robert J
Terry L. Jue, MD  Gastrointestinal Endoscopy 

Terry L. Jue, MD  Gastrointestinal Endoscopy 

Similar presentations

Ads by Google